Got $5,000? Hims & Hers Could Be a Direct‑to‑Consumer Health Moonshot in the Making
Hims & Hers is facing some well-deserved pushback from Novo Nordisk, but the big picture is still promising.
📰 Original Source
Read full article at Fool →KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.